BG62794B1 - Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество - Google Patents

Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество Download PDF

Info

Publication number
BG62794B1
BG62794B1 BG101080A BG10108096A BG62794B1 BG 62794 B1 BG62794 B1 BG 62794B1 BG 101080 A BG101080 A BG 101080A BG 10108096 A BG10108096 A BG 10108096A BG 62794 B1 BG62794 B1 BG 62794B1
Authority
BG
Bulgaria
Prior art keywords
carbamazepine
film
ratio
plasticizer
carbamasepin
Prior art date
Application number
BG101080A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101080A (en
Inventor
Karl-Friedrich Landgraf
Sabine Reiss
Eberhard Schubert
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of BG101080A publication Critical patent/BG101080A/xx
Publication of BG62794B1 publication Critical patent/BG62794B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG101080A 1994-07-01 1996-12-28 Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество BG62794B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de) 1994-07-01 1995-06-22 Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
BG101080A BG101080A (en) 1997-08-29
BG62794B1 true BG62794B1 (bg) 2000-08-31

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101080A BG62794B1 (bg) 1994-07-01 1996-12-28 Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество

Country Status (23)

Country Link
US (1) US5888545A (cs)
EP (1) EP0768882B1 (cs)
JP (1) JPH10502358A (cs)
KR (1) KR100344477B1 (cs)
CN (1) CN1101191C (cs)
AT (1) ATE169818T1 (cs)
BG (1) BG62794B1 (cs)
BR (1) BR9508202A (cs)
CA (1) CA2194216A1 (cs)
CZ (1) CZ288028B6 (cs)
DE (2) DE4423078B4 (cs)
DK (1) DK0768882T3 (cs)
EE (1) EE03954B1 (cs)
ES (1) ES2122630T3 (cs)
GE (1) GEP19991819B (cs)
HU (1) HU221486B (cs)
LT (1) LT4251B (cs)
LV (1) LV11820B (cs)
PL (1) PL180979B1 (cs)
RU (1) RU2141825C1 (cs)
SK (1) SK282303B6 (cs)
UA (1) UA32598C2 (cs)
WO (1) WO1996001112A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
CN101252932B (zh) * 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
LV11820B (en) 1997-12-20
KR100344477B1 (ko) 2002-11-23
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
SK282303B6 (sk) 2002-01-07
GEP19991819B (en) 1999-11-05
HU221486B (en) 2002-10-28
CZ288028B6 (cs) 2001-04-11
BG101080A (en) 1997-08-29
DE4423078A1 (de) 1996-01-04
ES2122630T3 (es) 1998-12-16
PL180979B1 (pl) 2001-05-31
CZ382696A3 (en) 1997-05-14
KR970703774A (ko) 1997-08-09
DE4423078B4 (de) 2005-01-13
HUT76821A (en) 1997-11-28
EE9600202A (et) 1997-06-16
JPH10502358A (ja) 1998-03-03
SK164696A3 (en) 1997-06-04
RU2141825C1 (ru) 1999-11-27
WO1996001112A1 (de) 1996-01-18
LT4251B (en) 1997-12-29
LV11820A (lv) 1997-08-20
CA2194216A1 (en) 1996-01-18
UA32598C2 (uk) 2001-02-15
ATE169818T1 (de) 1998-09-15
CN1153475A (zh) 1997-07-02
DK0768882T3 (da) 1999-05-25
PL317996A1 (en) 1997-05-12
BR9508202A (pt) 1997-11-11
CN1101191C (zh) 2003-02-12
LT97012A (en) 1997-08-25
HU9603565D0 (en) 1997-02-28
US5888545A (en) 1999-03-30
EE03954B1 (et) 2003-02-17
EP0768882B1 (de) 1998-08-19

Similar Documents

Publication Publication Date Title
EP0342522B1 (en) Peroral preparation of an acid-unstable compound
US6096340A (en) Omeprazole formulation
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
JP2653996B2 (ja) 徐放性薬剤
Pignatello, Davide Amico, Santina Chiechio, Concetta Spadaro, Giovanni Puglisi, Paolo Giunchedi Preparation and analgesic activity of eudragit RS100® microparticles containing diflunisal
AU2003269067A1 (en) Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
SE509029C2 (sv) Långtidsverkande diklofenak-natriumpreparat
AU2003269068A1 (en) Micropcapsules with modified release of active principles with low solubility for oral delivery
KR20010074914A (ko) 오메프라졸 제형
PT93029A (pt) Processo para a preparacao de uma composicao contendo acido 5-(2,5- dimetilfenoxi)-2,2-dimetil-pentanoico (gemfibrozilo) de libertacao modificada
CA2320387A1 (en) Medicinal compositions adhering to stomach/duodenum
JPH0157090B2 (cs)
SE448061B (sv) Forfarande for framstellning av farmaceutiskt aktiva kompositioner med kontrollerad frigoring av aktiva bestandsdelar der den aktiva komponenten overdragits med en polymerlosning i vilken en vattenfas er dispergerad
WO1995025516A1 (en) Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
US20020076444A1 (en) Novel method for obtaining microspheres and resulting products
BG62794B1 (bg) Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество
JPS58116414A (ja) ニカルジピン持続性製剤用球形顆粒およびその製造法
JPH06503577A (ja) 医薬組成物
JPH07112932A (ja) 徐放性医薬製剤
JPS59227817A (ja) 持続性経口用ブレデニン製剤
AU6224699A (en) Taste masking coating compositions
JPH06305960A (ja) チオウレア誘導体含有固形製剤
JPS6141325B2 (cs)
JPH07118154A (ja) 固体分散体および粒状製剤
JPS6024765B2 (ja) セフアレキシンの持続性製剤の製造方法